{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:05:57Z","timestamp":1794744357442,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Project of guiding innovation of clinical medical technology in Hunan province, China","award":["2021SK51408"],"award-info":[{"award-number":["2021SK51408"]}]},{"name":"Project of scientific research program of Hunan Health Committee, China","award":["B202303066210"],"award-info":[{"award-number":["B202303066210"]}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province, China","doi-asserted-by":"crossref","award":["2023JJ60486"],"award-info":[{"award-number":["2023JJ60486"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific research project of traditional Chinese medicine in Hunan province, China","award":["D2022091"],"award-info":[{"award-number":["D2022091"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-04893-z","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T14:25:36Z","timestamp":1745418336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect and underlying mechanism of Huangjing Qianshi decoction in pre-diabetes mouse model"],"prefix":"10.1186","volume":"25","author":[{"given":"Jialuo","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqi","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangzhong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanshan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"Suppl 1","key":"4893_CR1","first-page":"S15","volume":"44","author":"2","year":"2021","unstructured":"2. Classification and diagnosis of diabetes: standards of medical care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15\u201333.","journal-title":"Diabetes Care"},{"issue":"1","key":"4893_CR2","doi-asserted-by":"publisher","first-page":"e003203","DOI":"10.1136\/bmjdrc-2022-003203","volume":"11","author":"KW Teoh","year":"2023","unstructured":"Teoh KW, Ng CM, Chong CW, Bell S, Cheong WL, Lee SWH. Knowledge, attitude, and practice toward pre-diabetes among the public, patients with pre-diabetes and healthcare professionals: a systematic review. BMJ Open Diabetes Res Care. 2023;11(1):e003203.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"4","key":"4893_CR3","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s13300-019-0655-x","volume":"10","author":"Y Song","year":"2019","unstructured":"Song Y, Zhang X, Zhang H, Yang Q, Zhang S, Zhang Y, Chen Y, Ji Y, Hu X. Prevalence of diabetes and prediabetes in adults from a Third-Tier City in Eastern China: A Cross-Sectional study. Diabetes Therapy: Res Treat Educ Diabetes Relat Disorders. 2019;10(4):1473\u201385.","journal-title":"Diabetes Therapy: Res Treat Educ Diabetes Relat Disorders"},{"issue":"1","key":"4893_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13063-023-07116-3","volume":"24","author":"X Luo","year":"2023","unstructured":"Luo X, Wang Z, Li B, Zhang X, Li X. Effect of resistance vs. aerobic exercise in pre-diabetes: an RCT. Trials. 2023;24(1):110.","journal-title":"Trials"},{"issue":"1","key":"4893_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12902-023-01275-9","volume":"23","author":"P Mirmiran","year":"2023","unstructured":"Mirmiran P, Hosseini S, Bahadoran Z, Azizi F. Dietary pattern scores in relation to pre-diabetes regression to normal glycemia or progression to type 2 diabetes: a 9-year follow-up. BMC Endocr Disorders. 2023;23(1):20.","journal-title":"BMC Endocr Disorders"},{"issue":"14","key":"4893_CR6","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jama.2023.4063","volume":"329","author":"JB Echouffo-Tcheugui","year":"2023","unstructured":"Echouffo-Tcheugui JB, Perreault L, Ji L, Dagogo-Jack S. Diagnosis and management of prediabetes: A review. JAMA. 2023;329(14):1206\u201316.","journal-title":"JAMA"},{"issue":"1","key":"4893_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12906-022-03755-2","volume":"22","author":"PX Zhang","year":"2022","unstructured":"Zhang PX, Zeng L, Meng L, Li HL, Zhao HX, Liu DL. Observation on clinical effect of Huoxue-Jiangtang Decoction formula granules in treating prediabetes: a randomized prospective placebo-controlled double-blind trial protocol. BMC Complement Med Ther. 2022;22(1):274.","journal-title":"BMC Complement Med Ther"},{"issue":"11","key":"4893_CR8","first-page":"827","volume":"18","author":"SN Liu","year":"2020","unstructured":"Liu SN, Liu Q, Lei L, Sun SJ, Li CN, Huan Y, Hou SC, Shen ZF. The Chinese patent medicine, Jin-tang-ning, ameliorates hyperglycemia through improving \u0392 cell function in pre-diabetic KKAy mice. Chin J Nat Med. 2020;18(11):827\u201336.","journal-title":"Chin J Nat Med"},{"key":"4893_CR9","doi-asserted-by":"publisher","first-page":"942563","DOI":"10.3389\/fphar.2022.942563","volume":"13","author":"L Jiang","year":"2022","unstructured":"Jiang L, Wang S, Zhao J, Chien C, Zhang Y, Su G, Chen X, Song D, Chen Y, Huang W, et al. Treatment options of traditional Chinese patent medicines for dyslipidemia in patients with prediabetes: A systematic review and network meta-analysis. Front Pharmacol. 2022;13:942563.","journal-title":"Front Pharmacol"},{"key":"4893_CR10","doi-asserted-by":"publisher","first-page":"109878","DOI":"10.1016\/j.diabres.2022.109878","volume":"188","author":"L Jiang","year":"2022","unstructured":"Jiang L, Zhang Y, Zhang H, Chen Y, Huang W, Xiao Y, Aijia Shen E, Li Z, Xue T, Zhao J, et al. Comparative efficacy of 6 traditional Chinese patent medicines combined with lifestyle modification in patients with prediabetes: A network meta-analysis. Diabetes Res Clin Pract. 2022;188:109878.","journal-title":"Diabetes Res Clin Pract"},{"key":"4893_CR11","doi-asserted-by":"crossref","unstructured":"Xia S, Gao B, Chen S, Lin X, Zhang P, Chai Y, Li C, Asakawa T. Verification of the Efficacy and Safety of Qi-Replenishing Chinese Medicine in Treating Prediabetes: A Meta-Analysis and Literature Review. Evidence-based complementary and alternative medicine: eCAM. 2020;2020:7676281.","DOI":"10.1155\/2020\/7676281"},{"issue":"9","key":"4893_CR12","first-page":"546","volume":"55","author":"RMM Khan","year":"2019","unstructured":"Khan RMM, Chua ZJY, Tan JC, Yang Y, Liao Z, Zhao Y. From Pre-Diabetes to diabetes: diagnosis, treatments and translational research. Med (Kaunas Lithuania). 2019;55(9):546.","journal-title":"Med (Kaunas Lithuania)"},{"key":"4893_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.biochi.2022.08.021","volume":"204","author":"D Calder\u00f3n-DuPont","year":"2023","unstructured":"Calder\u00f3n-DuPont D, Torre-Villalvazo I, D\u00edaz-Villase\u00f1or A. Is insulin resistance tissue-dependent and substrate-specific? The role of white adipose tissue and skeletal muscle. Biochimie. 2023;204:48\u201368.","journal-title":"Biochimie"},{"key":"4893_CR14","doi-asserted-by":"crossref","unstructured":"Balakrishnan R, Thurmond DC. Mechanisms by which skeletal muscle myokines ameliorate insulin resistance. Int J Mol Sci 2022, 23(9).","DOI":"10.3390\/ijms23094636"},{"issue":"3","key":"4893_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.29271\/jcpsp.2022.03.303","volume":"32","author":"E Onalan","year":"2022","unstructured":"Onalan E, Bozkurt A, Gursu MF, Yakar B, Donder E. Role of betatrophin and inflammation markers in type 2 diabetes mellitus, prediabetes and metabolic syndrome. J Coll Physicians Surgeons\u2013Pakistan: JCPSP. 2022;32(3):303\u20137.","journal-title":"J Coll Physicians Surgeons\u2013Pakistan: JCPSP"},{"issue":"6","key":"4893_CR16","doi-asserted-by":"publisher","first-page":"e3405","DOI":"10.1002\/dmrr.3405","volume":"37","author":"JR Weaver","year":"2021","unstructured":"Weaver JR, Odanga JJ, Breathwaite EK, Treadwell ML, Murchinson AC, Walters G, Fuentes DP, Lee JB. An increase in inflammation and islet dysfunction is a feature of prediabetes. Diab\/Metab Res Rev. 2021;37(6):e3405.","journal-title":"Diab\/Metab Res Rev"},{"key":"4893_CR17","doi-asserted-by":"publisher","first-page":"107911","DOI":"10.1016\/j.diabres.2019.107911","volume":"158","author":"R Dimova","year":"2019","unstructured":"Dimova R, Chakarova N, Grozeva G, Kirilov G, Tankova T. The relationship between glucose variability and insulin sensitivity and oxidative stress in subjects with prediabetes. Diabetes Res Clin Pract. 2019;158:107911.","journal-title":"Diabetes Res Clin Pract"},{"key":"4893_CR18","unstructured":"Luc K, Schramm-Luc A, Guzik TJ, Mikolajczyk TP. Oxidative stress and inflammatory markers in prediabetes and diabetes. J Physiol Pharmacology: Official J Pol Physiological Soc 2019, 70(6)."},{"issue":"1","key":"4893_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000533966","volume":"17","author":"Y Li","year":"2024","unstructured":"Li Y, Dong X, He W, Quan H, Chen K, Cen C, Wei W. Ube2L6 promotes M1 macrophage polarization in High-Fat Diet-Fed obese mice via isgylation of STAT1 to trigger STAT1 activation. Obes Facts. 2024;17(1):24\u201336.","journal-title":"Obes Facts"},{"key":"4893_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.nbd.2018.05.019","volume":"117","author":"N Singh","year":"2018","unstructured":"Singh N, Lawana V, Luo J, Phong P, Abdalla A, Palanisamy B, Rokad D, Sarkar S, Jin H, Anantharam V, et al. Organophosphate pesticide Chlorpyrifos impairs STAT1 signaling to induce dopaminergic neurotoxicity: implications for mitochondria mediated oxidative stress signaling events. Neurobiol Dis. 2018;117:82\u2013113.","journal-title":"Neurobiol Dis"},{"key":"4893_CR21","doi-asserted-by":"publisher","first-page":"713750","DOI":"10.3389\/fphar.2021.713750","volume":"12","author":"M Yao","year":"2021","unstructured":"Yao M, Li L, Huang M, Tan Y, Shang Y, Meng X, Pang Y, Xu H, Zhao X, Lei W, et al. Sanye tablet ameliorates insulin resistance and dysregulated lipid metabolism in High-Fat Diet-Induced obese mice. Front Pharmacol. 2021;12:713750.","journal-title":"Front Pharmacol"},{"issue":"12","key":"4893_CR22","doi-asserted-by":"publisher","first-page":"e0144444","DOI":"10.1371\/journal.pone.0144444","volume":"10","author":"JD Sisler","year":"2015","unstructured":"Sisler JD, Morgan M, Raje V, Grande RC, Derecka M, Meier J, Cantwell M, Szczepanek K, Korzun WJ, Lesnefsky EJ, et al. The signal transducer and activator of transcription 1 (STAT1) inhibits mitochondrial biogenesis in liver and fatty acid oxidation in adipocytes. PLoS ONE. 2015;10(12):e0144444.","journal-title":"PLoS ONE"},{"issue":"1","key":"4893_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13098-023-01097-8","volume":"15","author":"Y Tian","year":"2023","unstructured":"Tian Y, Shi D, Liao H, Lu B, Pang Z. The role of Huidouba in regulating skeletal muscle metabolic disorders in prediabetic mice through AMPK\/PGC-1\u03b1\/PPAR\u03b1 pathway. Diabetol Metab Syndr. 2023;15(1):145.","journal-title":"Diabetol Metab Syndr"},{"issue":"4","key":"4893_CR24","first-page":"1039","volume":"47","author":"JL Cai","year":"2022","unstructured":"Cai JL, Li XP, Zhu YL, Deng GM, Yang L, Xia XH, Yi GQ, Chen XY. [Mechanism of Huangjing Qianshi Decoction in treatment of prediabetes based on network Pharmacology and molecular docking]. Zhongguo Zhong Yao Za zhi = Zhongguo Zhongyao Zazhi = China J Chin Materia Med. 2022;47(4):1039\u201350.","journal-title":"Zhongguo Zhong Yao Za zhi = Zhongguo Zhongyao Zazhi = China J Chin Materia Med"},{"issue":"4","key":"4893_CR25","first-page":"1032","volume":"48","author":"JL Cai","year":"2023","unstructured":"Cai JL, Zhu YL, Li XP, Xia XH, Deng GM, Tong QZ, Yi GQ, Cheng B. [Mechanism of Huangjing Qianshi Decoction in treatment of prediabetic mice based on transcriptome sequencing]. Zhongguo Zhong Yao Za zhi = Zhongguo Zhongyao Zazhi = China J Chin Materia Med. 2023;48(4):1032\u201342.","journal-title":"Zhongguo Zhong Yao Za zhi = Zhongguo Zhongyao Zazhi = China J Chin Materia Med"},{"issue":"1","key":"4893_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/19382014.2021.1982326","volume":"14","author":"KL Lee","year":"2022","unstructured":"Lee KL, Aitken JF, Li X, Montgomery K, Hsu HL, Williams GM, Brimble MA, Cooper GJS. Vesiculin derived from IGF-II drives increased islet cell mass in a mouse model of pre-diabetes. Islets. 2022;14(1):14\u201322.","journal-title":"Islets"},{"issue":"23","key":"4893_CR27","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/15287394.2024.2394586","volume":"87","author":"S Gali","year":"2024","unstructured":"Gali S, Kundu A, Sharma S, Ahn MY, Puia Z, Kumar V, Kim IS, Kwak JH, Palit P, Kim HS. Therapeutic potential of bark extracts from Macaranga denticulata on renal fibrosis in streptozotocin-induced diabetic rats. J Toxicol Environ Health Part A. 2024;87(23):911\u201333.","journal-title":"J Toxicol Environ Health Part A"},{"issue":"2","key":"4893_CR28","doi-asserted-by":"publisher","first-page":"10147","DOI":"10.1080\/21655979.2021.2001184","volume":"12","author":"JL Cai","year":"2021","unstructured":"Cai JL, Li XP, Zhu YL, Yi GQ, Wang W, Chen XY, Deng GM, Yang L, Cai HZ, Tong QZ, et al. Polygonatum sibiricum polysaccharides (PSP) improve the palmitic acid (PA)-induced Inhibition of survival, inflammation, and glucose uptake in skeletal muscle cells. Bioengineered. 2021;12(2):10147\u201359.","journal-title":"Bioengineered"},{"issue":"1","key":"4893_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13098-023-01050-9","volume":"15","author":"M AkbariRad","year":"2023","unstructured":"AkbariRad M, Shariatmaghani SS, Razavi BM, Majd HM, Shakhsemampour Z, Sarabi M, Jafari M, Azarkar S, Ghalibaf AM, Khorasani ZM. Probiotics for glycemic and lipid profile control of the pre-diabetic patients: a randomized, double-blinded, placebo-controlled clinical trial study. Diabetol Metab Syndr. 2023;15(1):71.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"4893_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/07853890.2022.2164347","volume":"55","author":"A Halalau","year":"2023","unstructured":"Halalau A, Roy S, Hegde A, Khanal S, Langnas E, Raja M, Homayouni R. Risk factors associated with glycated hemoglobin A1c trajectories progressing to type 2 diabetes. Ann Med. 2023;55(1):371\u20138.","journal-title":"Ann Med"},{"issue":"11","key":"4893_CR31","doi-asserted-by":"publisher","first-page":"300060521104829","DOI":"10.1177\/03000605211048293","volume":"49","author":"X Ha","year":"2021","unstructured":"Ha X, Cai X, Cao H, Li J, Yang B, Jiang R, Li X, Li B, Xin Y. Docking protein 1 and free fatty acids are associated with insulin resistance in patients with type 2 diabetes mellitus. J Int Med Res. 2021;49(11):3000605211048293.","journal-title":"J Int Med Res"},{"key":"4893_CR32","doi-asserted-by":"crossref","unstructured":"A ISS, C AB. A JS: Changes in plasma free fatty acids associated with Type-2 diabetes. Nutrients. 2019;11(9).","DOI":"10.3390\/nu11092022"},{"key":"4893_CR33","doi-asserted-by":"crossref","unstructured":"Liu Y, Ma C, Li P, Ma C, He S, Ping F, Zhang H, Li W, Xu L, Li Y. Potential Protective Effect of Dietary Intake of Non-\u03b1-Tocopherols on Cellular Aging Markers Mediated by Tumor Necrosis Factor-\u03b1 in Prediabetes: A Cross-Sectional Study of Chinese Adults. Oxidative medicine and cellular longevity 2020, 2020:7396801.","DOI":"10.1155\/2020\/7396801"},{"issue":"1","key":"4893_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jcb.26174","volume":"119","author":"MSH Akash","year":"2018","unstructured":"Akash MSH, Rehman K, Liaqat A. Tumor necrosis Factor-Alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2018;119(1):105\u201310.","journal-title":"J Cell Biochem"},{"key":"4893_CR35","doi-asserted-by":"crossref","unstructured":"Huang TH, Ke CH, Chen CC, Chuang CH, Liao KW, Shiao YH, Lin CS. The effects of freshwater clam (Corbicula fluminea) extract on serum tumor necrosis Factor-Alpha (TNF-\u03b1) in prediabetic patients in Taiwan. Mar Drugs 2022, 20(4).","DOI":"10.3390\/md20040261"},{"issue":"1","key":"4893_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12933-022-01465-0","volume":"21","author":"L La Sala","year":"2022","unstructured":"La Sala L, Tagliabue E, Mrakic-Sposta S, Uccellatore AC, Senesi P, Terruzzi I, Trabucchi E, Rossi-Bernardi L, Luzi L. Lower miR-21\/ROS\/HNE levels associate with lower glycemia after habit-intervention: DIAPASON study 1-year later. Cardiovasc Diabetol. 2022;21(1):35.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"4893_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1055\/a-1247-4978","volume":"130","author":"Z Cao","year":"2022","unstructured":"Cao Z, Yao F, Lang Y, Feng X. Elevated Circulating LINC-P21 serves as a diagnostic biomarker of type 2 diabetes mellitus and regulates pancreatic \u03b2-cell function by sponging miR-766-3p to upregulate NR3C2. Experimental and clinical endocrinology & diabetes: official journal. German Soc Endocrinol [and] German Diabetes Association. 2022;130(3):156\u201364.","journal-title":"German Soc Endocrinol [and] German Diabetes Association"},{"issue":"1","key":"4893_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/00207454.2020.1802265","volume":"132","author":"Y Huang","year":"2022","unstructured":"Huang Y, Wang Y, Ouyang Y. Elevated microRNA-135b-5p relieves neuronal injury and inflammation in post-stroke cognitive impairment by targeting NR3C2. Int J Neurosci. 2022;132(1):58\u201366.","journal-title":"Int J Neurosci"},{"key":"4893_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.brainresbull.2021.05.018","volume":"173","author":"C Wang","year":"2021","unstructured":"Wang C, Hu F. Long noncoding RNA SOX2OT Silencing alleviates cerebral ischemia-reperfusion injury via miR-135a-5p-mediated NR3C2 Inhibition. Brain Res Bull. 2021;173:193\u2013202.","journal-title":"Brain Res Bull"},{"issue":"15","key":"4893_CR40","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.7150\/ijms.47555","volume":"17","author":"S Hu","year":"2020","unstructured":"Hu S, Chen S, Li Z, Wang Y, Wang Y. Research on the potential mechanism of Chuanxiong rhizoma on treating diabetic nephropathy based on network Pharmacology. Int J Med Sci. 2020;17(15):2240\u20137.","journal-title":"Int J Med Sci"},{"issue":"6","key":"4893_CR41","doi-asserted-by":"publisher","first-page":"9011","DOI":"10.18632\/aging.202749","volume":"13","author":"K He","year":"2021","unstructured":"He K, Zhang J, Liu J, Cui Y, Liu LG, Ye S, Ban Q, Pan R, Liu D. Functional genomics study of protein inhibitor of activated STAT1 in mouse hippocampal neuronal cells revealed by RNA sequencing. Aging. 2021;13(6):9011\u201327.","journal-title":"Aging"},{"issue":"12","key":"4893_CR42","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.2337\/db15-0278","volume":"64","author":"Y Liu","year":"2015","unstructured":"Liu Y, Ge X, Dou X, Guo L, Liu Y, Zhou SR, Wei XB, Qian SW, Huang HY, Xu CJ, et al. Protein inhibitor of activated STAT 1 (PIAS1) protects against Obesity-Induced insulin resistance by inhibiting inflammation cascade in adipose tissue. Diabetes. 2015;64(12):4061\u201374.","journal-title":"Diabetes"},{"issue":"1","key":"4893_CR43","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41420-021-00765-w","volume":"7","author":"Z Hou","year":"2021","unstructured":"Hou Z, Chen J, Yang H, Hu X, Yang F. PIAS1 alleviates diabetic peripheral neuropathy through sumolation of PPAR-\u03b3 and miR-124-induced downregulation of EZH2\/STAT3. Cell Death Discovery. 2021;7(1):372.","journal-title":"Cell Death Discovery"},{"key":"4893_CR44","doi-asserted-by":"publisher","first-page":"104216","DOI":"10.1016\/j.dci.2021.104216","volume":"125","author":"S Lu","year":"2021","unstructured":"Lu S, Peng X, Zeng S, Deng H, Feng Z, Zeng Q, Cheng X, Hu J, Ye Z, Li M, et al. Grass carp (Ctenopharyngodon idellus) PIAS1 inhibits innate immune response via interacting with STAT1. Dev Comp Immunol. 2021;125:104216.","journal-title":"Dev Comp Immunol"},{"issue":"Pt A","key":"4893_CR45","doi-asserted-by":"publisher","first-page":"107030","DOI":"10.1016\/j.intimp.2020.107030","volume":"89","author":"X Su","year":"2020","unstructured":"Su X, Zhang Q, Yue J, Wang Y, Zhang Y, Yang R. TRIM59 suppresses NO production by promoting the binding of PIAS1 and STAT1 in macrophages. Int Immunopharmacol. 2020;89(Pt A):107030.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"4893_CR46","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1007\/s13300-021-01058-2","volume":"12","author":"JL Tarry-Adkins","year":"2021","unstructured":"Tarry-Adkins JL, Grant ID, Ozanne SE, Reynolds RM, Aiken CE. Efficacy and side effect profile of different formulations of metformin: A systematic review and Meta-Analysis. Diabetes Therapy: Res Treat Educ Diabetes Relat Disorders. 2021;12(7):1901\u201314.","journal-title":"Diabetes Therapy: Res Treat Educ Diabetes Relat Disorders"},{"issue":"2","key":"4893_CR47","first-page":"225","volume":"29","author":"M Hameed","year":"2017","unstructured":"Hameed M, Khan K, Salman S, Mehmood N. Dose comparison and side effect profile of Metformin extended release versus Metformin immediate release. J Ayub Med Coll Abbottabad: JAMC. 2017;29(2):225\u20139.","journal-title":"J Ayub Med Coll Abbottabad: JAMC"},{"key":"4893_CR48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.51866\/cr.282","volume":"18","author":"MH Ngu","year":"2023","unstructured":"Ngu MH, Zakaria R, Mohd Zulkifli M, Ab Rahman R. Erectile dysfunction as a possible important side effect of metformin: A case report. Malaysian Family Physician: Official J Acad Family Physicians Malaysia. 2023;18:20.","journal-title":"Malaysian Family Physician: Official J Acad Family Physicians Malaysia"},{"issue":"3","key":"4893_CR49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.6065\/apem.2142210.105","volume":"27","author":"YM Yu","year":"2022","unstructured":"Yu YM, So SKC, Khallouq BB. The effect of Metformin on vitamin B12 level in pediatric patients. Annals Pediatr Endocrinol Metabolism. 2022;27(3):223\u20138.","journal-title":"Annals Pediatr Endocrinol Metabolism"},{"issue":"03","key":"4893_CR50","first-page":"100","volume":"17","author":"J Cai","year":"2021","unstructured":"Cai J, Zhu Y, Zhou L, Pan W, Yang H, Yang L, Zhang Z, Tong Q, Li X, Yi G. Clinical effect of Huangjing Qianshi Decoction on prediabetes. Asia-Pacific Traditional Med (Chinese). 2021;17(03):100\u20133.","journal-title":"Asia-Pacific Traditional Med (Chinese)"},{"key":"4893_CR51","doi-asserted-by":"crossref","unstructured":"Nason SR, Kim T, Antipenko JP, Finan B, DiMarchi R, Hunter CS, Habegger KM. Glucagon-Receptor signaling reverses hepatic steatosis independent of leptin receptor expression. Endocrinology 2020, 161(1).","DOI":"10.1210\/endocr\/bqz013"},{"issue":"2","key":"4893_CR52","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/hep.26043","volume":"57","author":"FK Huynh","year":"2013","unstructured":"Huynh FK, Neumann UH, Wang Y, Rodrigues B, Kieffer TJ, Covey SD. A role for hepatic leptin signaling in lipid metabolism via altered very low density lipoprotein composition and liver lipase activity in mice. Hepatology (Baltimore MD). 2013;57(2):543\u201354.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"7","key":"4893_CR53","doi-asserted-by":"publisher","first-page":"6828","DOI":"10.3390\/ijms24076828","volume":"24","author":"S Zahid","year":"2023","unstructured":"Zahid S, Dafre AL, Currais A, Yu J, Schubert D, Maher P. The geroprotective drug candidate CMS121 alleviates diabetes, liver inflammation, and renal damage in Db\/db leptin receptor deficient mice. Int J Mol Sci. 2023;24(7):6828.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4893_CR54","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.2337\/db09-0878","volume":"59","author":"RC Davis","year":"2010","unstructured":"Davis RC, Castellani LW, Hosseini M, Ben-Zeev O, Mao HZ, Weinstein MM, Jung DY, Jun JY, Kim JK, Lusis AJ, et al. Early hepatic insulin resistance precedes the onset of diabetes in obese C57BLKS-db\/db mice. Diabetes. 2010;59(7):1616\u201325.","journal-title":"Diabetes"},{"key":"4893_CR55","doi-asserted-by":"crossref","unstructured":"Wu G, Gu W, Cheng H, Guo H, Li D, Xie Z. Huangshan Maofeng Green Tea Extracts Prevent Obesity-Associated Metabolic Disorders by Maintaining Homeostasis of Gut Microbiota and Hepatic Lipid Classes in Leptin Receptor Knockout Rats. Foods (Basel, Switzerland). 2022;11(19).","DOI":"10.3390\/foods11192939"},{"key":"4893_CR56","doi-asserted-by":"publisher","first-page":"106004","DOI":"10.1016\/j.fitote.2024.106004","volume":"176","author":"J Campbell-Tofte","year":"2024","unstructured":"Campbell-Tofte J, Mu H, Winther K, M\u00f8lgaard P, Belin N, Josefsen K. Standardization parameters and synergism of source plant materials for the antidiabetic efficacy of the Rauvolfia-Citrus tea. Fitoterapia. 2024;176:106004.","journal-title":"Fitoterapia"},{"issue":"6566","key":"4893_CR57","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/379632a0","volume":"379","author":"GH Lee","year":"1996","unstructured":"Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 1996;379(6566):632\u20135.","journal-title":"Nature"},{"issue":"1","key":"4893_CR58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.plefa.2006.09.002","volume":"76","author":"J Campbell-Tofte","year":"2007","unstructured":"Campbell-Tofte J, Hansen HS, Mu H, M\u00f8lgaard P. Increased lipids in non-lipogenic tissues are indicators of the severity of type 2 diabetes in mice. Prostaglandins Leukot Essent Fat Acids. 2007;76(1):9\u201318.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"4893_CR59","doi-asserted-by":"publisher","first-page":"15942","DOI":"10.1038\/srep15942","volume":"5","author":"D Bao","year":"2015","unstructured":"Bao D, Ma Y, Zhang X, Guan F, Chen W, Gao K, Qin C, Zhang L. Preliminary characterization of a leptin receptor knockout rat created by CRISPR\/Cas9 system. Sci Rep. 2015;5:15942.","journal-title":"Sci Rep"},{"issue":"4","key":"4893_CR60","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1293\/tox.2019-0021","volume":"32","author":"S Chisada","year":"2019","unstructured":"Chisada S, Sugiyama A. Renal lesions in leptin receptor-deficient Medaka (Oryzias latipes). J Toxicologic Pathol. 2019;32(4):297\u2013303.","journal-title":"J Toxicologic Pathol"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-04893-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-04893-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-04893-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T15:03:28Z","timestamp":1745420608000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-025-04893-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4893"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-04893-z","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"30 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The experimental protocol was approved by the Ethics Committee of the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine (approval number: ZYFY20220615-23) in accordance with ARRIVE guidelines. This study did not involve clinical trials; hence, the Clinical Trial Number was not provided in the manuscript. We only mentioned our previous clinical research (reference 50) on HJQST in the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not Applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}